Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03994367 · ClinicalTrials.gov registry record · NA
Animal and Plant Proteins and Glucose Metabolism
A NA study of Metabolic Syndrome and Glucose Metabolism Disorders, sponsored by University of Missouri-Columbia.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT03994367: Recruiting NA study of Metabolic Syndrome and Glucose Metabolism Disorders, sponsored by University of Missouri-Columbia.
NCT03994367 is a NA study of Metabolic Syndrome and Glucose Metabolism Disorders that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 100 participants, below the 1,204-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03994367, a NA study of Metabolic Syndrome and Glucose Metabolism Disorders, is actively recruiting participants, sponsored by University of Missouri-Columbia.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this proposal is to determine the effect of a high protein diet in which the increase in protein intake is derived from different sources (animal vs plant and protein-rich whole foods vs protein isolates) on: i) liver and muscle insulin sensitivity; ii) the metabolic response to a meal, and iii) 24-h plasma concentration profiles of glucose, glucoregulatory hormones, and protein-derived metabolites purported to cause metabolic dysfunction.
Conditions Studied
Interventions
- OTHER High animal protein isolate
- OTHER High animal protein whole food
- OTHER High plant protein isolate
- OTHER High plant protein whole food
Study Locations (1)
Missouri
- University of Missouri School of Medicine - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-07-12 |
| Est. Completion | 2028-04-25 |
| Phase | NA |
What NCT03994367 shows while recruiting
NCT03994367 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,204-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (92% lower).
The record links to 3 conditions, with Metabolic Syndrome appearing as the primary indexed condition, and to 4 interventions - of which High animal protein isolate is the first listed.
NCT03994367 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03994367 about?
NCT03994367 is a clinical study titled "Animal and Plant Proteins and Glucose Metabolism". The goal of this proposal is to determine the effect of a high protein diet in which the increase in protein intake is derived from different sources (animal vs plant and protein-rich whole foods vs protein isolates) on: i) liver and muscle insulin sensitivity; ii) the metabolic response to a meal, ...
What is the current status of trial NCT03994367?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2019-07-12. Estimated completion is 2028-04-25.
What conditions does trial NCT03994367 study?
This clinical trial studies the following conditions: Metabolic Syndrome, Glucose Metabolism Disorders, Metabolic Syndrome, Protection Against.
What interventions are being tested in trial NCT03994367?
The interventions under investigation include: High animal protein isolate (OTHER), High animal protein whole food (OTHER), High plant protein isolate (OTHER), High plant protein whole food (OTHER).
Who is sponsoring clinical trial NCT03994367?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03994367 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03994367's enrollment target sits among peer trials
100 32nd of 102 higher than 70 of 102 other Metabolic Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metabolic Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
VR Stimulation of Exercise Response in Sedentary Humans
RECRUITING · NA
-
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
-
Physical Activity Targeting Metabolic Syndrome for Prevention of Breast Cancer in SAI Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI